Tigerland Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 43.88%
- Profit Growth 61.15%
- Ebitda 525.74%
- Net Worth 11.48%
- Total Assets -4.06%
About Tigerland Life Science
Tigerland Life Science Private Limited (TLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 November 2016 (Eight years and three months 21 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kizhekke Harinarayanan and Kizhekke Namboodiri serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232KL2016PTC047179
- Company No.
047179
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Nov 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Tigerland Life Science?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kizhekke Harinarayanan  | Managing Director | 02-Nov-2016 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kizhekke Namboodiri | Director | 16-Sep-2020 | Current |
Financial Performance of Tigerland Life Science.
Tigerland Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 43.88% increase. The company also saw a substantial improvement in profitability, with a 61.15% increase in profit. The company's net worth Soared by an impressive increase of 11.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tigerland Life Science?
In 2017, Tigerland Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Tigerland Electric Systems LlpKizhekke Harinarayanan and Kizhekke Namboodiri are mutual person
- Navodaya Energy Private Limited
Kizhekke Namboodiri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tigerland Life Science?
Unlock and access historical data on people associated with Tigerland Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tigerland Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tigerland Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
